Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

[Dutch government invests in existing biobanks].

Brandsma M, van Ommen GJ, Wijmenga C, Kiemeney LA.

Ned Tijdschr Geneeskd. 2010;154:A2825. Dutch.

PMID:
21029488
2.

[Biobanking and Biomolecular Resources Research Infrastructure (BBMRI). Implications for pathology].

Viertler C, Zatloukal K.

Pathologe. 2008 Nov;29 Suppl 2:210-3. doi: 10.1007/s00292-008-1048-5. German.

PMID:
18810444
3.

[Ethical review of biobanks in The Netherlands: lessons from the String of Pearls Initiative].

Boeckhout M, van Dijk J, Legemate DA.

Ned Tijdschr Geneeskd. 2011;155(26):A3557. Review. Dutch.

PMID:
21767425
4.

Biobanks: transnational, European and global networks.

Asslaber M, Zatloukal K.

Brief Funct Genomic Proteomic. 2007 Sep;6(3):193-201. Epub 2007 Oct 4.

PMID:
17916592
5.

Biobankonomics: a taxonomy for evaluating the economic benefits of standardized centralized human biobanking for translational research.

Rogers J, Carolin T, Vaught J, Compton C.

J Natl Cancer Inst Monogr. 2011;2011(42):32-8. doi: 10.1093/jncimonographs/lgr010.

PMID:
21672893
6.

The Organization of European Cancer Institute Pathobiology Working Group and its support of European biobanking infrastructures for translational cancer research.

Riegman PH, de Jong BW, Llombart-Bosch A.

Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):923-6. doi: 10.1158/1055-9965.EPI-10-0062. Epub 2010 Mar 23.

7.

Biobank governance: trends and perspectives.

Gottweis H, Zatloukal K.

Pathobiology. 2007;74(4):206-11.

8.

Commercial biobanks and genetic research: ethical and legal issues.

Anderlik M.

Am J Pharmacogenomics. 2003;3(3):203-15. Review.

PMID:
12814328
9.

Biobanking for interdisciplinary clinical research.

Riegman PH, Dinjens WN, Oosterhuis JW.

Pathobiology. 2007;74(4):239-44.

PMID:
17709966
10.

Access Governance for Biobanks: The Case of the BioSHaRE-EU Cohorts.

Kaye J, Briceño Moraia L, Mitchell C, Bell J, Bovenberg JA, Tassé AM, Knoppers BM.

Biopreserv Biobank. 2016 Jun;14(3):201-6. doi: 10.1089/bio.2015.0124. Epub 2016 May 16.

PMID:
27183185
12.

The Biobank of Nephrological Diseases in the Netherlands cohort: the String of Pearls Initiative collaboration on chronic kidney disease in the university medical centers in the Netherlands.

Navis GJ, Blankestijn PJ, Deegens J, De Fijter JW, Homan van der Heide JJ, Rabelink T, Krediet RT, Kwakernaak AJ, Laverman GD, Leunissen KM, van Paassen P, Vervloet MG, Wee PM, Wetzels JF, Zietse R, van Ittersum FJ; BIND-NL investigators.

Nephrol Dial Transplant. 2014 Jun;29(6):1145-50. doi: 10.1093/ndt/gft307. Epub 2013 Oct 22. Review.

PMID:
24151018
13.

[Experience with establishment and operation of a biobank].

Stege A, Hummel M.

Pathologe. 2008 Nov;29 Suppl 2:214-7. doi: 10.1007/s00292-008-1043-x. German.

PMID:
18712392
14.

[Biobanks and the return of results to donors].

Vermeulen E, Boeckhout M, Zielhuis GA, Bakker R, Janssens AC, Schmidt MK.

Ned Tijdschr Geneeskd. 2014;158(5):A6653. Review. Dutch.

PMID:
24472337
15.

The interface of population-based cancer registries and biobanks in etiological and clinical research--current and future perspectives.

Andersson K, Bray F, Arbyn M, Storm H, Zanetti R, Hallmans G, Coebergh JW, Dillner J.

Acta Oncol. 2010 Nov;49(8):1227-34. doi: 10.3109/0284186X.2010.496792. Epub 2010 Jun 29. Review.

PMID:
20583946
16.

International and national initiatives in biobanking.

Ectors N.

Verh K Acad Geneeskd Belg. 2011;73(1-2):5-40. Review.

PMID:
22276394
17.

The Genome of the Netherlands: design, and project goals.

Boomsma DI, Wijmenga C, Slagboom EP, Swertz MA, Karssen LC, Abdellaoui A, Ye K, Guryev V, Vermaat M, van Dijk F, Francioli LC, Hottenga JJ, Laros JF, Li Q, Li Y, Cao H, Chen R, Du Y, Li N, Cao S, van Setten J, Menelaou A, Pulit SL, Hehir-Kwa JY, Beekman M, Elbers CC, Byelas H, de Craen AJ, Deelen P, Dijkstra M, den Dunnen JT, de Knijff P, Houwing-Duistermaat J, Koval V, Estrada K, Hofman A, Kanterakis A, Enckevort Dv, Mai H, Kattenberg M, van Leeuwen EM, Neerincx PB, Oostra B, Rivadeneira F, Suchiman EH, Uitterlinden AG, Willemsen G, Wolffenbuttel BH, Wang J, de Bakker PI, van Ommen GJ, van Duijn CM.

Eur J Hum Genet. 2014 Feb;22(2):221-7. doi: 10.1038/ejhg.2013.118. Epub 2013 May 29.

18.

BBMRI-ERIC: the novel gateway to biobanks. From humans to humans.

Mayrhofer MT, Holub P, Wutte A, Litton JE.

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Mar;59(3):379-84. doi: 10.1007/s00103-015-2301-8.

PMID:
26860601
19.

Informed consent in biobank research: a deliberative approach to the debate.

Secko DM, Preto N, Niemeyer S, Burgess MM.

Soc Sci Med. 2009 Feb;68(4):781-9. doi: 10.1016/j.socscimed.2008.11.020. Epub 2008 Dec 16.

PMID:
19095337
20.

Children and biobanks: a review of the ethical and legal discussion.

Hens K, Lévesque E, Dierickx K.

Hum Genet. 2011 Sep;130(3):403-13. doi: 10.1007/s00439-011-1031-8. Epub 2011 Jun 10. Review.

PMID:
21660506

Supplemental Content

Support Center